MULTIVITAMIN FORMULATION (IMPACT) FOR PREVENTION AND MANAGEMENT OF ACUTE INFECTIONS

摘要

This invention relates to a Multivitamin formulation (Impact) for prevention and management of acute infections comprising 2.04-2.76 mg Beta Carotene USP (as 20% powder), 4250-5750 IU Vitamin-A IP (as Acetate), 340-460 IU Vitamin D3 IP (Cholecalciferol), 12.75-17.25 IU Vitamin E acetate IP (as 50% Powder), 63.75-86.25 mg Vitamin C IP, 3.825-5.175mg Vitamin Bl IP (Thiamine Mononitrate), 4.25-5.75 mg Vitamin B2 IP (Riboflavine), 38.25-51. 75mg Nicainamide IP, 0.85-1.15 mg Folic Acid IP, 4.25-5.75mcg Calcicum Pantothenate IP, 17-23 meg Biotin USP, 1.275-1.725 mg Vitamin B6 IP (Pyridoxine HCI), 4.25-5.75 mg Vit.B12 IP (Cyanocobalarnin), 85-115 mg Calcium Phosphate Dibasic IP eq. to Calcium, 131.75-178.25 mg Phophorous, 85-115 meg Potassium Iodide IP eq. to Iodine, 42.5-57.5 mg Magnesium Oxide Light IP eq. to Magnesium, 9.35-12.65 mg Zinc Sulphate Monohydrate USP eq. to Zinc, 391-529 meg Copper Sulphate IP 66 eq. to Copper, 123.25-166.75 meg Selenium Dioxide eq. to Selenium, 42.5-57.5 meg Chromic Chloride USP, 2.55-3.45 mg Manganese Sulphate USP eq. to Manganese, 34-46 meg Sodium Molybdate eq. to Molybdenum, 51-69 mg Ginsing, 2.55-3.45 mg Co-enzyme Q10, 0.85-1.15 mg Lutein, 21.25-28.75 mg L Lysine, 0.85-1.15 mg Lycopene and 4.25-5.75 mg Acetylecystene. .